Literature DB >> 29106985

The chemokine receptor CCR2 maintains plasmacytoid dendritic cell homeostasis.

Oriane Cédile1, Line Østerby Jørgensen2, Ida Frank3, Agnieszka Wlodarczyk4, Trevor Owens5.   

Abstract

Thymic dendritic cells (DC) play a role in central tolerance. Three thymic DC subtypes have been described: plasmacytoid DC (pDC) and two conventional DC (cDC), CD8α+ Sirpα- DC and Sirpα+ CD8α- cDC. Both pDC and Sirpα+ cDC can take up antigen in periphery and migrate into the thymus in response to chemokine signaling via CCR9 and CCR2 respectively. CCL2 is a major ligand for CCR2 and we previously showed that it was constitutively expressed in thymus, and that mice overexpressing CCL2 in thymus had reduced numbers of autoreactive T cells but elevated numbers of pDC. We have here investigated the role of CCL2-CCR2 axis in thymic pDC migration. We found that pDC expressed CCR2 at a high level and that their frequency was decreased in thymus, spleen and inguinal lymph nodes in mice lacking CCR2, but not in mice lacking CCL2. pDC migration towards the cortex or medulla within the thymus was not affected by CCL2 or CCR2 deficiency. Although some thymic progenitors expressed CCR2, this did not include those that give rise to pDC. Based on these results, we propose that CCR2 is involved in pDC homeostasis but its ligand CCL2 does not play a major role.
Copyright © 2017 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CCL2; CCR2; Chemokine; Plasmacytoid dendritic cells

Mesh:

Substances:

Year:  2017        PMID: 29106985     DOI: 10.1016/j.imlet.2017.10.012

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  2 in total

1.  Lymphotoxin α fine-tunes T cell clonal deletion by regulating thymic entry of antigen-presenting cells.

Authors:  Noëlla Lopes; Jonathan Charaix; Oriane Cédile; Arnauld Sergé; Magali Irla
Journal:  Nat Commun       Date:  2018-03-28       Impact factor: 14.919

2.  Predictive value of plasmacytoid dendritic cells and Toll-like receptor-9 regarding the treatment efficacy of interferon-α in HBeAg-positive chronic hepatitis B patients.

Authors:  Yue Chen; Jia-En Yang; Jing-Mo Tang; Qian-Guo Mao; Qi-Zhong Zheng; Ying Zheng
Journal:  Exp Ther Med       Date:  2019-11-01       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.